Former CDER division director joins Lightlake Therapeutics
This article was originally published in SRA
Executive Summary
The UK-based early stage biopharmaceutical company Lightlake Therapeutics has appointed Cynthia McCormick as a senior clinical and regulatory advisor. Dr McCormick is the former director of the division of anaesthetic, critical care and addiction drug products at the Office of Drug Evaluation, part of the Center for Drug Evaluation and Research at the US Food and Drug Administration.